Antibody Discovery
Isogenica can help you initiate innovative biopharmaceutical programmes
Synthetic Fab Antibody Fragment Libraries
Isogenica's large and highly diverse Fab libraries are a starting point for the development of high-affinity and developable therapeutic IgGs
Synthetic Camelid Single-Domain (VHH) Libraries
Isogenica's range of diverse synthetic VHH antibody libraries provide quick access to camelid single domain biotherapeutics
In vitro Polypeptide Display Technology
Isogenica's CIS Display system is a rapid and effective way to select biotherapeutics from large polypeptide libraries

Welcome to Isogenica

Isogenica's advanced synthetic antibody libraries and display technologies enable and accelerate our partners' therapeutic antibody discovery programmes

Read More

Next Generation Synthetic Antibody Libraries

In Vitro Display Technology

Partnering

Events

News

23
Aug

Antibody Engineering & Therapeutics 2018

San Diego, CA, USA | 9th-13th December 2018

Join us for our presentation on how Isogenica can accelerate biotherapeutic discovery

23
Aug

PEGS Summit Europe 2018

Lisbon, Portugal | 12th November to 16th November 2018

Isogenica is pleased to be attending and presenting at PEGS Europe 2018. We look forward to meeting you there.

News

22
Aug

Isogenica appoints Dr Emma Sceats as Chief Executive Officer

Cambridge, UK, 3rd September 2018

Isogenica CEO will join Isogenica’s Board of Directors with immediate effect.

24
Jul

VHH antibodies as biotherapeutics

Why single domain antibody fragments are the best biologic alternative to therapeutic IgGs

Download the infographic